Sara Fendia is 1989 graduate of the University of Houston Law Center. Prior to entering law school she spent a number of years in the world of business and has successfully incorporated the tools and experience she acquired in the business world into her more than 28 years in the legal field, adding an advantageous dimension to her practice. Sara has developed a distinct experience in handling mass tort litigation, such as the national multi-million dollar FenPhen, Vioxx, Zyprexa and National Medical Enterprises litigations. She has successfully represented clients against major corporations such as Wyeth Pharmaceuticals, Eli Lilly and Company, Merck & Co., Avis Rent A Car System, Tenant Healthcare, Halliburton, and Kellogg Brown & Root, as well as a number of smaller entities.